ENSG00000136352


Homo sapiens

Features
Gene ID: ENSG00000136352
  
Biological name :NKX2-1
  
Synonyms : NK2 homeobox 1 / NKX2-1 / P43699
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 14
Strand: -1
Band: q13.3
Gene start: 36516392
Gene end: 36521149
  
Corresponding Affymetrix probe sets: 210673_x_at (Human Genome U133 Plus 2.0 Array)   211024_s_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000449302
Ensembl peptide - ENSP00000346879
Ensembl peptide - ENSP00000428341
Ensembl peptide - ENSP00000429519
Ensembl peptide - ENSP00000429607
NCBI entrez gene - 7080     See in Manteia.
OMIM - 600635
RefSeq - NM_001079668
RefSeq - NM_003317
RefSeq Peptide - NP_001073136
RefSeq Peptide - NP_003308
swissprot - F8VVG2
swissprot - P43699
Ensembl - ENSG00000136352
  
Related genetic diseases (OMIM): 118700 - Chorea, hereditary benign, 118700
  188550 - {Thyroid cancer, nonmedullary, 1}, 188550
  610978 - Choreoathetosis, hypothyroidism, and neonatal respiratory distress, 610978

This gene has been taged as a transcription factor by TFT
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 nkx2.1ENSDARG00000019835Danio rerio
 Nkx2-1ENSMUSG00000001496Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
NKX2-4 / Q9H2Z4 / NK2 homeobox 4ENSG0000012581652
NKX2-3 / Q8TAU0 / NK2 homeobox 3ENSG0000011991927
A6NCS4 / NKX2-6 / NK2 homeobox 6ENSG0000018005326
NKX2-5 / P52952 / NK2 homeobox 5ENSG0000018307225
NKX2-2 / O95096 / NK2 homeobox 2ENSG0000012582024
NKX2-8 / O15522 / NK2 homeobox 8ENSG0000013632721
NKX3-2 / P78367 / NK3 homeobox 2ENSG0000010970520
HMX3 / A6NHT5 / H6 family homeobox 3ENSG0000018862015
NKX3-1 / Q99801 / NK3 homeobox 1ENSG0000016703414
HMX2 / A2RU54 / H6 family homeobox 2ENSG0000018881613
HMX1 / Q9NP08 / H6 family homeobox 1ENSG0000021561213


Protein motifs (from Interpro)
Interpro ID Name
 IPR001356  Homeobox domain
 IPR009057  Homeobox-like domain superfamily
 IPR017970  Homeobox, conserved site
 IPR020479  Homeobox domain, metazoa


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0000122 negative regulation of transcription by RNA polymerase II IDA
 biological_processGO:0001764 neuron migration IEA
 biological_processGO:0006351 transcription, DNA-templated IEA
 biological_processGO:0006355 regulation of transcription, DNA-templated IEA
 biological_processGO:0006357 regulation of transcription by RNA polymerase II IEA
 biological_processGO:0006644 phospholipid metabolic process IEA
 biological_processGO:0007389 pattern specification process IEA
 biological_processGO:0007411 axon guidance IEA
 biological_processGO:0007420 brain development IMP
 biological_processGO:0007492 endoderm development IEA
 biological_processGO:0007626 locomotory behavior IEA
 biological_processGO:0009725 response to hormone IEP
 biological_processGO:0009887 animal organ morphogenesis IEA
 biological_processGO:0010628 positive regulation of gene expression IDA
 biological_processGO:0010719 negative regulation of epithelial to mesenchymal transition IDA
 biological_processGO:0021537 telencephalon development IEA
 biological_processGO:0021759 globus pallidus development IMP
 biological_processGO:0021766 hippocampus development IEA
 biological_processGO:0021795 cerebral cortex cell migration IEA
 biological_processGO:0021798 forebrain dorsal/ventral pattern formation IEA
 biological_processGO:0021877 forebrain neuron fate commitment IEA
 biological_processGO:0021879 forebrain neuron differentiation IEA
 biological_processGO:0021892 cerebral cortex GABAergic interneuron differentiation IEA
 biological_processGO:0021895 cerebral cortex neuron differentiation IEA
 biological_processGO:0021983 pituitary gland development IEA
 biological_processGO:0022029 telencephalon cell migration IEA
 biological_processGO:0030324 lung development IEP
 biological_processGO:0030336 negative regulation of cell migration IDA
 biological_processGO:0030512 negative regulation of transforming growth factor beta receptor signaling pathway IDA
 biological_processGO:0030878 thyroid gland development IMP
 biological_processGO:0030900 forebrain development IEP
 biological_processGO:0031128 developmental induction IEA
 biological_processGO:0033327 Leydig cell differentiation IEA
 biological_processGO:0042753 positive regulation of circadian rhythm ISS
 biological_processGO:0045892 negative regulation of transcription, DNA-templated ISS
 biological_processGO:0045893 positive regulation of transcription, DNA-templated ISS
 biological_processGO:0045944 positive regulation of transcription by RNA polymerase II IDA
 biological_processGO:0048511 rhythmic process IEA
 biological_processGO:0048646 anatomical structure formation involved in morphogenesis IEA
 biological_processGO:0048663 neuron fate commitment IEA
 biological_processGO:0048709 oligodendrocyte differentiation IEA
 biological_processGO:0060430 lung saccule development IEA
 biological_processGO:0060441 epithelial tube branching involved in lung morphogenesis IEP
 biological_processGO:0060486 Clara cell differentiation IEA
 biological_processGO:0060510 type II pneumocyte differentiation IEA
 cellular_componentGO:0005634 nucleus IEA
 cellular_componentGO:0005654 nucleoplasm ISS
 cellular_componentGO:0005667 transcription factor complex IEA
 molecular_functionGO:0000977 RNA polymerase II regulatory region sequence-specific DNA binding IDA
 molecular_functionGO:0000981 RNA polymerase II transcription factor activity, sequence-specific DNA binding NAS
 molecular_functionGO:0001012 RNA polymerase II regulatory region DNA binding IDA
 molecular_functionGO:0001047 core promoter binding ISS
 molecular_functionGO:0001161 intronic transcription regulatory region sequence-specific DNA binding ISS
 molecular_functionGO:0003677 DNA binding IMP
 molecular_functionGO:0003700 DNA-binding transcription factor activity IMP
 molecular_functionGO:0003705 transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding IEA
 molecular_functionGO:0005515 protein binding IPI
 molecular_functionGO:0019899 enzyme binding IPI
 molecular_functionGO:0043565 sequence-specific DNA binding IEA
 molecular_functionGO:0044212 transcription regulatory region DNA binding IMP
 molecular_functionGO:0044213 intronic transcription regulatory region DNA binding IDA


Pathways (from Reactome)
Pathway description
No match


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000006 Autosomal dominant inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele." [HPO:curators]
Show

 HP:0000158 Macroglossia "Increased length and width of the tongue." [pmid:19125428]
Show

 HP:0000239 Large fontanelles "In newborns, the two frontal bones, two parietal bones, and one occipital bone are joined by fibrous sutures, which form a small posterior fontanelle, and a larger, diamond-shaped anterior fontanelle. These regions allow for the skull to pass the birth canal and for later growth. The fontanelles gradually ossify, whereby the posterior fontanelle usually closes by eight weeks and the anterior fontanelle by the 9th to 16th month of age. Large fontanelles are diagnosed if the fontanelles are larger than age-dependent norms." [HPO:curators]
Show

 HP:0000280 Coarse facial features 
Show

 HP:0000739 Anxiety 
Show

 HP:0000821 Hypothyroidism 
Show

 HP:0000851 Congenital hypothyroidism 
Show

 HP:0001251 Ataxia "Ataxia is a nonspecific neurological sign and symptom consisting of gross lack of coordination of muscle movements. Ataxia is caused by dysfunction of one or more parts of the nervous system including the cerebellum, the sensory nervous system, the vestibular system, or the cerebral cortex." [HPO:curators]
Show

 HP:0001252 Muscular hypotonia "Muscular hypotonia is an abnormally low muscle tone (the amount of tension or resistance to movement in a muscle), often involving reduced muscle strength. Hypotonia is characterized by a diminished resistance to passive stretching." [HPO:curators]
Show

 HP:0001260 Dysarthria "Dysarthric speech is a general description referring to a neurological speech disorder characterized by poor articulation. Depending on the involved neurological structures, dysarthria may be further classified as spastic, flaccid, ataxic, hyperkinetic and hypokinetic, or mixed." [HPO:curators]
Show

 HP:0001263 Developmental retardation "A delay in the achievement of motor or mental milestones manifested prior to age 18 and generally associated with lifelong mental and/or physical impairments." [HPO:curators]
Show

 HP:0001266 Choreoathetosis 
Show

 HP:0001270 Motor retardation 
Show

 HP:0001288 Gait disturbance "The term gait disturbance can refer to any disruption of the ability to walk. In general, this can refer to neurological diseases but also fractures or other sources of pain that is triggered upon walking. However, in the current context gait disturbance refers to difficulty walking on the basis of a neurological or muscular disease." [HPO:curators]
Show

 HP:0001290 Generalized hypotonia "Generalized muscular hypotonia (abnormally low muscle tone)." [HPO:curators]
Show

 HP:0001324 Muscle weakness "Reduced strength of muscles." [HPO:curators]
Show

 HP:0001332 Dystonia "An abnormally increased muscular tone that causes fixed abnormal postures. There is a slow, intermittent twisting motion that leads to exaggerated turning and posture of the extremities and trunk." [HPO:curators]
Show

 HP:0001629 Ventricular septal defect "A hole between the two bottom chambers (ventricles) of the heart. The defect is centered around the most superior aspect of the ventricular septum." [HPO:curators]
Show

 HP:0001631 Atrial septal defect "Atrial septal defect (ASD) is a congenital heart defect that enables blood flow between the left and right atria via the interatrial septum. The three common types of ASD are sinus venosus defects, ostium secundum defects, and ostium primum defects." [HPO:curators]
Show

 HP:0001671 Abnormality of the cardiac septa 
Show

 HP:0002019 Constipation 
Show

 HP:0002072 Chorea "Chorea (Greek for dance ) refers to widespread arrhythmic involuntary movements of a forcible, jerky and restless fashion." [HPO:curators]
Show

 HP:0002098 Respiratory distress 
Show

 HP:0002099 Asthma "Asthma is characterized by increased responsiveness of the tracheobronchial tree to multiple stimuli, leading to narrowing of the air passages with resultant dyspnea, cough, and wheezing." [HPO:curators]
Show

 HP:0002205 Recurrent respiratory infections 
Show

 HP:0002355 Difficulty walking 
Show

 HP:0002360 Sleep disturbances "An abnormality of sleep including such phenomena as 1) insomnia/hypersomnia, 2) non-restorative sleep, 3) sleep schedule disorder, 4) excessive daytime somnolence, 5) sleep apnea, and 6) restlessness." [HPO:curators]
Show

 HP:0002643 Neonatal respiratory distress 
Show

 HP:0002925 Increased serum thyroid-stimulating hormone (TSH) 
Show

 HP:0003270 Abdominal distention "Enlargement or distention of the abdomen, which can be a secondary feature associated with a number of conditions such as bowel obstruction." [HPO:curators]
Show

 HP:0003577 Onset at birth 
Show

 HP:0003621 Juvenile onset 
Show

 HP:0003812 Phenotypic variability 
Show

 HP:0004322 Decreased body height "A height below that which is expected according to age and gender norms. Although there is no universally accepted definition of short stature, many refer to "short stature" as height more than 2 standard deviations below the mean for age and gender (or below the 3rd percentile for age and gender dependent norms)." [HPO:curators]
Show

 HP:0008191 Athyroidal hypothyroidism 
Show

 HP:0008223 Compensated hypothyroidism 
Show

 HP:0010864 Mental retardation, severe "Moderate mental retardation is defined as an intelligence quotient (IQ) in the range of 20-34." [HPO:probinson]
Show

 HP:0011968 Feeding difficulties "Impaired ability to eat related to problems gathering food and getting ready to suck, chew, or swallow it." [ISCA:eriggs]
Show

 HP:0012378 Fatigue "A subjective feeling of tiredness characterized by a lack of energy and motivation." [HPO:probinson]
Show

 HP:0100786 Hypersomnia 
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
No match






 

1 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr